Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147491 | SCV000194927 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000205475 | SCV000259978 | benign | Spastic paraplegia | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313717 | SCV000848502 | benign | Inborn genetic diseases | 2016-08-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001668129 | SCV001891817 | benign | not provided | 2019-01-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847614 | SCV002105203 | likely benign | Hereditary spastic paraplegia | 2017-08-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001668129 | SCV005210618 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000020648 | SCV000041175 | not provided | Allan-Herndon-Dudley syndrome | no assertion provided | literature only | ||
Clinical Genetics, |
RCV000147491 | SCV001923767 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000147491 | SCV001966919 | benign | not specified | no assertion criteria provided | clinical testing |